![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Wyeth |
Information provided by: | Wyeth |
ClinicalTrials.gov Identifier: | NCT00428051 |
To determine the incidence of invasive pneumococcal disease in Latin America
Condition | Intervention |
Pneumococcal Disease |
Procedure: Blood Culture |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | Multinational Latin American Epidemiologic Surveillance for Invasive Pneumococcal Disease |
Blood cultures; Additional speciments from other sterile sites (e.g., pleural fluid, CSF, joint fluid) will be collected as per routine medical practice
Estimated Enrollment: | 4000 |
Study Start Date: | September 2006 |
Estimated Study Completion Date: | April 2009 |
Groups/Cohorts | Assigned Interventions |
1
Suspected Invasive Pneumococcal disease
|
Procedure: Blood Culture
Blood cultures; Additional speciments from other sterile sites (e.g., pleural fluid, CSF, joint fluid) will be collected as per routine medical practice
|
Ages Eligible for Study: | up to 3 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Children (ages 28 days to 36 months of age) with possible invasive pneumococcal disease
Inclusion Criteria:
Exclusion Criteria:
Contact: Trial Manager | clintrialparticipation@wyeth.com |
Brazil | |||||
Recruiting | |||||
Goiania, Brazil, 74605-050 | |||||
Colombia, DC | |||||
Recruiting | |||||
Bogota, DC, Colombia, 27-28 | |||||
Costa Rica, San Jose | |||||
Recruiting | |||||
La Uruca, San Jose, Costa Rica, 1150 | |||||
Mexico | |||||
Active, not recruiting | |||||
Durango, Mexico, 34000 |
Wyeth |
Study Director: | Medical Monitor | Wyeth |
Responsible Party: | Wyeth ( Wyeth (Clinical Trials Registry Specialist) ) |
Study ID Numbers: | 0887X1-900 |
First Received: | January 25, 2007 |
Last Updated: | December 21, 2007 |
ClinicalTrials.gov Identifier: | NCT00428051 |
Health Authority: | Colombia: INVIMA Instituto Nacional de Vigilancia de Medicamentos y Alimentos |
|
|
![]() |